$PROB
// Fluconazole clinical PK module
// Source: Debruyne D, Ryckelynck JP. Clin Pharmacokinet. 1993;24:10-27.
// DOI: 10.2165/00003088-199324010-00002
// Population: Adults from clinical pharmacokinetic studies summarized in the source review.
// Provenance: deterministic PK module imported from DDI Manager+.
// OMEGA and SIGMA below are engineering priors added for MAP compatibility; they were not estimated in the cited source.

$PARAM @annotated
TVCL : 1 : Typical clearance (L/h)
TVV  : 50 : Typical volume (L)
TVKA : 1.5 : First-order absorption rate (1/h)
TVF  : 0.9 : Oral bioavailability
ETA1 : 0 : MAP random effect on clearance

$OMEGA @annotated
IIV_CL : 0.09 : Engineering prior variance on clearance

$SIGMA @annotated
PROP : 0.04 : Engineering prior proportional residual variance

$CMT @annotated
GUT  : Oral depot [ADM]
CENT : Central compartment [OBS]

$MAIN
double CL = TVCL * exp(ETA1 + ETA(1));
double V = TVV;

$ODE
dxdt_GUT = -TVKA * GUT;
dxdt_CENT = TVKA * GUT * TVF - (CL / V) * CENT;

$TABLE
double IPRED = CENT / V;
double DV = IPRED * (1.0 + EPS(1));

$CAPTURE DV CL
